Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
18.70
-0.23 (-1.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Sanara MedTech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 103.12 | 86.67 | 64.99 | 45.84 | 24.14 | Upgrade
|
| Revenue Growth (YoY) | 18.97% | 33.36% | 41.77% | 89.87% | 54.90% | Upgrade
|
| Cost of Revenue | 7.52 | 8.14 | 7.85 | 6.36 | 2.31 | Upgrade
|
| Gross Profit | 95.6 | 78.53 | 57.14 | 39.48 | 21.83 | Upgrade
|
| Selling, General & Admin | 78.72 | 71.67 | 56.99 | 46.09 | 28.26 | Upgrade
|
| Research & Development | 5.07 | 2.83 | 4.13 | 3.07 | 0.36 | Upgrade
|
| Operating Expenses | 86.45 | 76.78 | 64.8 | 51.53 | 29.21 | Upgrade
|
| Operating Income | 9.15 | 1.75 | -7.67 | -12.05 | -7.38 | Upgrade
|
| Interest Expense | -6.76 | -3.13 | -0.48 | - | -0 | Upgrade
|
| Interest & Investment Income | 0 | 0.02 | - | - | - | Upgrade
|
| Earnings From Equity Investments | -0.95 | -0.09 | - | -0.38 | -0.62 | Upgrade
|
| EBT Excluding Unusual Items | 1.44 | -1.45 | -8.14 | -12.43 | -7.99 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -0.19 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.25 | -1.04 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.01 | - | - | - | - | Upgrade
|
| Asset Writedown | -1.84 | -0.51 | - | - | - | Upgrade
|
| Other Unusual Items | - | 0.01 | 3.45 | -0.28 | - | Upgrade
|
| Pretax Income | -0.39 | -1.94 | -4.44 | -13.94 | -7.99 | Upgrade
|
| Income Tax Expense | - | - | - | -5.84 | - | Upgrade
|
| Earnings From Continuing Operations | -0.39 | -1.94 | -4.44 | -8.09 | -7.99 | Upgrade
|
| Earnings From Discontinued Operations | -37.17 | -7.73 | - | - | - | Upgrade
|
| Net Income to Company | -37.57 | -9.67 | -4.44 | -8.09 | -7.99 | Upgrade
|
| Minority Interest in Earnings | 0.01 | 0 | 0.14 | 0.15 | 0.07 | Upgrade
|
| Net Income | -37.56 | -9.66 | -4.3 | -7.94 | -7.92 | Upgrade
|
| Net Income to Common | -37.56 | -9.66 | -4.3 | -7.94 | -7.92 | Upgrade
|
| Shares Outstanding (Basic) | 9 | 8 | 8 | 8 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 8 | 8 | 8 | 7 | Upgrade
|
| Shares Change (YoY) | 1.64% | 2.48% | 4.71% | 7.70% | 28.02% | Upgrade
|
| EPS (Basic) | -4.36 | -1.14 | -0.52 | -1.00 | -1.08 | Upgrade
|
| EPS (Diluted) | -4.36 | -1.14 | -0.52 | -1.00 | -1.08 | Upgrade
|
| Free Cash Flow | 2.16 | -0.23 | -3.51 | -5.7 | -4.99 | Upgrade
|
| Free Cash Flow Per Share | 0.25 | -0.03 | -0.42 | -0.72 | -0.68 | Upgrade
|
| Gross Margin | 92.71% | 90.61% | 87.92% | 86.13% | 90.43% | Upgrade
|
| Operating Margin | 8.87% | 2.02% | -11.79% | -26.27% | -30.55% | Upgrade
|
| Profit Margin | -36.43% | -11.15% | -6.62% | -17.32% | -32.81% | Upgrade
|
| Free Cash Flow Margin | 2.10% | -0.27% | -5.40% | -12.44% | -20.65% | Upgrade
|
| EBITDA | 11.81 | 4.03 | -3.99 | -9.67 | -6.78 | Upgrade
|
| EBITDA Margin | 11.45% | 4.65% | -6.14% | -21.10% | -28.08% | Upgrade
|
| D&A For EBITDA | 2.66 | 2.28 | 3.68 | 2.37 | 0.6 | Upgrade
|
| EBIT | 9.15 | 1.75 | -7.67 | -12.05 | -7.38 | Upgrade
|
| EBIT Margin | 8.87% | 2.02% | -11.79% | -26.27% | -30.55% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.